Literature DB >> 1864535

Serum and tissue autoantibodies to colonic epithelium in ulcerative colitis.

J A Snook1, J R Lowes, K C Wu, J D Priddle, D P Jewell.   

Abstract

Sera and colonic tissue-bound immunoglobulin extracts from patients with ulcerative colitis and disease controls were examined immunohistochemically and by killer cell cytotoxicity assay for the presence of anticolonic epithelial autoantibodies. IgG yields in the tissue extracts from patients with colitis and control subjects were similar, and the extracts were uniformly autoantibody negative. Of 41 sera from patients with inflammatory bowel disease, 'classical' anticolon antibody was present in 41% and was commoner in patients with sclerosing cholangitis. Cytotoxic anticolon antibody was present in 20% overall and was strongly associated with disease activity; it did not correlate with the presence of 'classical' anticolon antibody. The heterogeneous and non-universal antiepithelial autoantibody response and the failure to detect tissue bound autoantibody in vivo argue against the hypothesis that humoral autoimmunity is of major importance in the pathogenesis of ulcerative colitis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1864535      PMCID: PMC1378800          DOI: 10.1136/gut.32.2.163

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  12 in total

1.  Effects of preliminary incubation of lymphocytes with serum on their cytotoxicity for colonic epithelial cells.

Authors:  R G Shorter; K A Huizenga; S G ReMine; R J Spencer
Journal:  Gastroenterology       Date:  1970-06       Impact factor: 22.682

2.  Auto-immune reactions in ulcerative colitis.

Authors:  R Wright; S C Truelove
Journal:  Gut       Date:  1966-02       Impact factor: 23.059

3.  Isolation and characterization of a colonic autoantigen specifically recognized by colon tissue-bound immunoglobulin G from idiopathic ulcerative colitis.

Authors:  F Takahashi; K M Das
Journal:  J Clin Invest       Date:  1985-07       Impact factor: 14.808

4.  Serum autoantibodies, ulcerative colitis and primary sclerosing cholangitis.

Authors:  R W Chapman; M Cottone; W S Selby; H A Shepherd; S Sherlock; D P Jewell
Journal:  Gut       Date:  1986-01       Impact factor: 23.059

5.  Inflammatory bowel disease: study of cell mediated cytotoxicity for isolated human colonic epithelial cells.

Authors:  B J Kemler; E Alpert
Journal:  Gut       Date:  1980-05       Impact factor: 23.059

6.  Detection of colonic antigen(s) in tissues from ulcerative colitis using purified colitis colon tissue-bound IgG (CCA-IgG).

Authors:  T Nagai; K M Das
Journal:  Gastroenterology       Date:  1981-09       Impact factor: 22.682

7.  Ulcerative colitis specific cytotoxic IgG-autoantibodies against colonic epithelial cancer cells.

Authors:  I O Auer; L Grosch; C Hardörfer; A Röder
Journal:  Gut       Date:  1988-12       Impact factor: 23.059

8.  Antibody-dependent cell-mediated cytotoxicity in serum samples from patients with ulcerative colitis. Relationship to disease activity and response to total colectomy.

Authors:  K M Das; Y Kadono; G M Fleischner
Journal:  Am J Med       Date:  1984-11       Impact factor: 4.965

9.  The posttranslational processing of sucrase-isomaltase in HT-29 cells is a function of their state of enterocytic differentiation.

Authors:  G Trugnan; M Rousset; I Chantret; A Barbat; A Zweibaum
Journal:  J Cell Biol       Date:  1987-05       Impact factor: 10.539

10.  In vitro studies of ulcerative colitis. I. Reactions of patients' serum with human fetal colon cells in tissue cultures.

Authors:  O BROBERGER; P PERLMANN
Journal:  J Exp Med       Date:  1963-05-01       Impact factor: 14.307

View more
  13 in total

Review 1.  Autoantibodies in primary sclerosing cholangitis.

Authors:  Johannes-Roksund Hov; Kirsten-Muri Boberg; Tom-H Karlsen
Journal:  World J Gastroenterol       Date:  2008-06-28       Impact factor: 5.742

2.  Serum and tissue autoantibodies to colonic epithelium in ulcerative colitis.

Authors:  K M Das
Journal:  Gut       Date:  1991-12       Impact factor: 23.059

3.  Circulating immunoglobulin G1 antibody in patients with ulcerative colitis against the colonic epithelial protein detected by a novel monoclonal antibody.

Authors:  A Dasgupta; A Mandal; K M Das
Journal:  Gut       Date:  1994-12       Impact factor: 23.059

4.  Detection of anti-colon antibodies in inflammatory bowel disease using human cultured colonic cells.

Authors:  J C Lee; A M Cevallos; A Naeem; J E Lennard-Jones; M J Farthing
Journal:  Gut       Date:  1999-02       Impact factor: 23.059

5.  Antibodies to colonic epithelial cells from the serum and colonic mucosal washings in ulcerative colitis.

Authors:  U Y Khoo; I Bjarnason; A Donaghy; R Williams; A Macpherson
Journal:  Gut       Date:  1995-07       Impact factor: 23.059

6.  Expression of a unique protein on colon cancer cells that reacts with a novel monoclonal antibody and ulcerative colitis serum.

Authors:  T Hassan; Y Kanisawa; S Meyers; A Dasgupta; K M Das
Journal:  Clin Exp Immunol       Date:  1995-06       Impact factor: 4.330

7.  Anti-lactoferrin antibodies and other types of ANCA in ulcerative colitis, primary sclerosing cholangitis, and Crohn's disease.

Authors:  E Peen; S Almer; G Bodemar; B O Rydén; C Sjölin; K Tejle; T Skogh
Journal:  Gut       Date:  1993-01       Impact factor: 23.059

8.  Epithelial deposits of immunoglobulin G1 and activated complement colocalise with the M(r) 40 kD putative autoantigen in ulcerative colitis.

Authors:  T S Halstensen; K M Das; P Brandtzaeg
Journal:  Gut       Date:  1993-05       Impact factor: 23.059

9.  Systemic antibodies towards mucosal bacteria in ulcerative colitis and Crohn's disease differentially activate the innate immune response.

Authors:  E Furrie; S Macfarlane; J H Cummings; G T Macfarlane
Journal:  Gut       Date:  2004-01       Impact factor: 23.059

10.  Interleukin 2 and interferon-gamma augment anticolon antibody dependent cellular cytotoxicity in ulcerative colitis.

Authors:  T Hibi; M Ohara; M Watanabe; T Kanai; H Takaishi; A Hayashi; Y Hosoda; H Ogata; Y Iwao; S Aiso
Journal:  Gut       Date:  1993-06       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.